News & Events

New BD BACTEC™ FX Blood Culture System with the BD EpiCenter™ Microbiology Data Management System now Available Worldwide

(February 26, 2009) --

Can Facilitate Fast and Effective Clinical Decisions for Patients with Bacterial Infections

The new BD BACTEC™ FX Blood Culture System to detect bloodstream infections interfaced to the BD EpiCenter™ Microbiology Data Management System is now available worldwide.

The BD BACTEC™ FX System enables remote observation of blood culture data from outside the microbiology laboratory through integration with the BD EpiCenter™ Microbiology Data Management System. This new system improves clinical decision-making and laboratory workflow by markedly improving blood culturing practices with real-time, remotely accessible, actionable results that can enhance patient care.  The BD BACTEC™ FX System is designed to continue the media performance excellence expected from the BD BACTEC™ line: from Plus and Lytic to Peds and media for yeast, fungi or mycobacteria recovery.

“The system utilizes the breadth of current media containing our patented resin that provides unmatched recovery of pathogens from the blood,” said David Panneton, Vice President, WW Marketing, BD Diagnostics – Diagnostic Systems. “It is the result of 40 years of blood-culturing expertise and customer interaction, with more than 10,000 blood culture instruments installed worldwide.”

“The new BD BACTEC™ FX System responds to customer requests for a space-saving and efficient blood culture workflow process by reducing hands-on time and enhanced blood culture observation both inside and outside of the microbiology lab. This is achieved in combination with the BD EpiCenter™ Microbiology Data Management System. This innovative capability allows clinician access to laboratory results during any shift and provides a visible and audible alarm on the remote BD EpiCenter™ client or on an existing computer monitor in a more highly occupied area of the lab. All of the information is available 24 hours a day, seven days a week by fax, e-mail, mobile phone text messaging or beeper to any off-site healthcare professional. Lab personnel no longer need to interrupt evening or midnight workflow to repeatedly check with the microbiology department for positive blood cultures.

By providing data access at the same remote computer that provides the alarm, the system facilitates
immediate decision-making.  With the information provided, clinicians can initiate appropriate next steps to diagnose the infection, such as performing a Gram stain, subculture, or direct identification of Staphylococcus aureus or methicillin-resistant Staphylococcus aureus with the BD GeneOhm™ StaphSR assay.  These steps could lead to earlier, appropriate clinical decisions for effective antimicrobial interventions.

Multi-source data integration provides comprehensive reporting capabilities across all BD BACTEC™ FX and BD BACTEC™ 9000 blood culture instruments, eliminating the need for manual report consolidation on more than five instruments. Data from numerous BD BACTEC™ FX instruments can be consolidated into one reporting system with the BD EpiCenter™ system. When combined with the BD Phoenix™ Automated Microbiology System, BD EpiCenter™ will provide rapid and synchronized blood culture, bacterial identification and susceptibility information flow to the laboratorian and physician, enhancing patient care.

The BD BACTEC™ FX System maintains the proven high performance and instrument reliability of its predecessor, the BD BACTEC™ 9000 System. It retains the fluorescent technology that represents excellence in blood culture isolate recovery, along with exceptional instrument and media performance. The BD BACTEC™ FX System has a compact and versatile system design.  It offers a 200-vial benchtop unit or a full 400-vial stack that includes an embedded, centralized computer - all in a highly compact 24-inch linear space which represents the smallest and most reliable design available.

Among the first BD BACTEC™ FX global owners are:

  • King Faisal Specialist Hospital & Research Center, Riyadh,  Kingdom of Saudi Arabia
  • Vancouver General Hospital in Vancouver, British Columbia
  • The Hospital for Sick Children in Toronto, Ontario
  • County Durham and Darlington NHS Foundation Trust in Darlington, United Kingdom
  • Poole Hospital in Dorset, United Kingdom.

Additionally, BD has seen successful BD BACTEC™ FX implementation in the United States, Australia and Europe.

For more information please contact us